2.8. Secondary Outcomes
fatty liver
FATTY LIVER, SECONDARY, INSULIN SENSITIVITY
The secondary outcomes of the main trial are changes from baseline in waist circumference, body weight, fasting plasma glucose (FPG), 2 h plasma glucose (2 h-PG) and the Matsuda whole body insulin sensitivity index (Matsuda ISIThe secondary outcomes of the Ectopic Fat sub-study are change from baseline in intramyocellular lipid (IMCL), fatty liver index (FLI) [